首页> 外文期刊>European journal of pharmaceutical sciences >Improving the skin penetration and antifebrile activity of ibuprofen by preparing nanoparticles using emulsion solvent evaporation method
【24h】

Improving the skin penetration and antifebrile activity of ibuprofen by preparing nanoparticles using emulsion solvent evaporation method

机译:使用乳液溶剂蒸发法制备纳米颗粒改善布洛芬的皮肤渗透和抗真血纤维活性

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Ibuprofen (IBU) is an effective analgesic, non-steroidal anti-inflammatory drug. Unfortunately, oral IBU can cause adverse gastrointestinal drug reactions, such as bleeding and ulcerations, and increases the risk for stomach or intestinal perforations. In this study, IBU nanoparticles (IBU-NPs) were prepared through emulsion solvent evaporation and freeze-drying to improve their solubility. IBU nanoemulsion and nanosuspension were optimized through a single-factor experiment. IBU-NPs with a mean particle size of 216.9±10.7nm were produced under optimum conditions. These IBU-NPs were characterized by using scanning electron microscopy, X-ray diffraction, differential scanning calorimetry, and residual solvent determination to determine their solvent residue, equilibrium solubility, dissolution rate, in vitro transdermal rate, transdermal bioavailability, and antifebrile experiment for febrile rats. The morphological characteristic of IBU-NPs showed porous clusters. Analysis results indicated that the prepared IBU-NPs have low crystallinity. Residual amounts of ethanol and chloroform were 170 and 9.6ppm, respectively, which were less than the ICH limit for class II. Measurement analysis showed that the IBU-NPs were converted underwent amorphous states after preparation, but the chemical structure of the IBU-NPs was unchanged. Transdermal bioavailability of IBU in the IBU-NP group improved significantly compared with oral and transdermal raw IBU. Furthermore, the IBU-NP transdermal gel exhibited a high and stable cooling rate and a long cooling duration in febrile rats. In comparison with the raw oral IBU and raw IBU transdermal gel, the IBU-NP transdermal gel manifested better efficacy at low and mid doses. Basing from the results, we conclude that IBU-NPs can be applied in transdermal delivery formulations and have potential application value for non-oral administration. Graphical abstract Display Omitted
机译:摘要布洛芬(IBU)是一种有效的镇痛,非甾体类抗炎药。不幸的是,口服IBU可能导致胃肠道药物反应,例如出血和溃疡,并增加胃或肠穿孔的风险。在该研究中,通过乳液溶剂蒸发和冷冻干燥来制备IBU纳米颗粒(IBU-NPS)以改善它们的溶解度。通过单因素实验优化了IBU纳米乳剂和纳米溶血性。在最佳条件下生产平均粒径为216.9±10.7nm的IBU-NPS。通过使用扫描电子显微镜,X射线衍射,差示扫描量热法,以及残留溶剂测定来表征这些IBU-NPS,以确定其溶剂残留物,平衡溶解度,溶解速率,透皮率,透皮性生物利用度和抗真用实验老鼠。 IBU-NPS显示多孔簇的形态学特征。分析结果表明,制备的IBU-NP具有低结晶度。残留量的乙醇和氯仿分别为170和9.6ppm,分别小于II类的ICH限制。测量分析表明,在制备后,IBU-NP转化后部的无定形状态,但IBU-NP的化学结构不变。与口腔和透皮原始IBU相比,IBU-NP组IBU在IBU中的透皮生物利用度改善了。此外,IBU-NP透皮凝胶在发热大鼠中表现出高且稳定的冷却速率和长冷却持续时间。与原始口服IBU和RAW IBU透皮凝胶相比,IBU-NP透皮凝胶在低和中剂量下表现出更好的疗效。结果从结果中,我们得出结论,IBU-NP可以应用于透皮递送制剂,并具有非口服给药的潜在应用价值。省略了图形抽象显示

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号